Search

Displaying results 4101 - 4110 of 10000 in total
  1. Indication

    Chronic Ulcer of Skin

    go.drugbank.com/conditions/DBCOND0159402
    Drugs: Hyaluronic acid
    Synonyms: Non-pressure chronic ulcer of skin, not elsewhere classified, Skin ulcer NOS
  2. Indication

    Noncystic Fibrosis Bronchiectasis (NCFB)

    go.drugbank.com/conditions/DBCOND0134357
    Drugs: Brensocatib
    Synonyms: Bronchiectasis NOS, Bronchiectasis, NOS
  3. Drug

    Bisphosphocin Nu-3

    go.drugbank.com/drugs/DB16015
    Investigational

    Bisphosphocin Nu-3 is under investigation in clinical trial NCT02737722 (Topically Applied Bisphosphocin Nu-3 on Infected Diabetic Ulcers of Subjects With Type I or II Diabetes Mellitus).

    Synonyms: Nu-3, Bisphosphocin Nu-3
  4. Drug

    Dengue virus serotype 2

    go.drugbank.com/drugs/DB22665
    Approved

    [A274008] It is one of four serotypes covered by Qdenga, a live, attenuated, tetravalent vaccine used for the prevention of dengue disease.

  5. Drug

    Dengue virus serotype 3

    go.drugbank.com/drugs/DB22666
    Approved

    [A274008] It is one of four serotypes covered by Qdenga, a live, attenuated, tetravalent vaccine used for the prevention of dengue disease.

  6. Indication

    Dyspepsia

    go.drugbank.com/conditions/DBCOND0004526
    Drugs: Alginic acid · Almasilate · Aluminium glycinate · Aluminium phosphate · Aluminum hydroxide · Anise oil +27 more
    Synonyms: Non Ulcer Dyspepsia, Dyspepsia, NOS
  7. Drug

    OSI-930

    go.drugbank.com/drugs/DB05913
    Investigational

    In preclinical studies, OSI-930 shows broad efficacy in tumor models representative of small cell lung cancer, glioblastoma, colorectal, renal, head and neck, non-small cell lung cancer and gastric cancers

  8. Drug

    Bifeprunox

    go.drugbank.com/drugs/DB04888
    Investigational

    Bifeprunox is a novel atypical antipsychotic agent which, along with SLV313, aripiprazole and SSR-181507 combines minimal D2 receptor agonism with 5-HT receptor agonism.

  9. Drug

    Etazolate

    go.drugbank.com/drugs/DB05881
    Investigational

    EHT 0202 is developed to treat neurodegenerative disorders by ExonHit Therapeutics.

  10. Drug

    Meningococcal polysaccharide vaccine group A

    go.drugbank.com/drugs/DB13889
    ApprovedInvestigational

    It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup A. … *N. meningitidis* is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia.